Harmonet

Harmonet is a prescription combined oral contraceptive tablet that contains the synthetic estrogen ethinylestradiol and the progestin gestodene. It is formulated as an oral tablet (strength not specified) and is marketed in the European Union. The product belongs to the hormonal contraceptive class and works by preventing ovulation, altering cervical mucus, and inducing endometrial changes to reduce the risk of pregnancy through daily use.

Harmonet is indicated for hormonal contraception in women of reproductive age. - Prevention of pregnancy in women seeking a reversible, oral contraceptive method. - Regulation of menstrual cycle and reduction of dysmenorrhea. - Management of acne related to androgen excess. - Decrease of risk for ovarian cyst formation. - Provision of a predictable withdrawal bleed during the placebo interval. - Use as part of a combined hormonal regimen for cycle control.

Like other combined oral contraceptives, Harmonet may cause a range of side effects, most of which are mild, transient, and resolve without medical intervention. Users should be aware of typical reactions as well as rare but serious events. Common: - Nausea, vomiting, or mild gastrointestinal discomfort. - Headache, migraine, or transient dizziness. - Breast tenderness, swelling, or mild pain. - Irregular spotting, breakthrough bleeding, or changes in menstrual flow. - Mood changes, irritability, or mild depression. - Weight fluctuations, fluid retention, or increased appetite. Serious: - Blood clots such as deep vein thrombosis, pulmonary embolism, or stroke. - Severe hypertension, heart attack, or other cardiovascular complications. - Liver dysfunction, jaundice, or severe abdominal pain indicating hepatic issues.

Before prescribing Harmonet, clinicians evaluate individual risk factors and counsel patients on safety considerations to minimize adverse outcomes. - Contraindicated in women who are pregnant, breastfeeding, or have known hypersensitivity to any component. - Avoid use in patients with a history of thromboembolic disorders, stroke, or myocardial infarction. - Caution in smokers over 35 years of age due to increased cardiovascular risk. - Assess liver disease, gallbladder pathology, or uncontrolled hypertension before initiation. - Monitor for signs of depression, mood swings, or severe headaches during therapy. - Discuss potential interactions with other hormonal medications and the need for backup contraception if doses are missed.

Harmonet can interact with several prescription and over‑the‑counter agents, altering its effectiveness or increasing the risk of side effects. Avoid: - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin, rifampicin) that markedly reduce contraceptive efficacy. - Certain antibiotics such as griseofulvin that may decrease hormone levels. - Combined use with hormonal replacement therapy may increase estrogen exposure. Use with caution: - Antifungal agents (e.g., ketoconazole, itraconazole) that can increase plasma concentrations of ethinylestradiol. - St. John’s wort, a herbal inducer, which may lower contraceptive effectiveness. - Selective serotonin reuptake inhibitors (SSRIs) that may increase the risk of bleeding. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that can enhance hypertension risk.